Premium
Bicara Therapeutics, a biotech firm floated by Kiran Mazumdar’s niece Claire Mazumdar, has secured $108 million in a Series B funding exercise. The startup had earlier raised an undisclosed capital in a seed round from Biocon, which was also its subsidiary, before spinning off in 2021. The new round was co-led ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
